Adhesive Capsulitis (Frozen Shoulder)

Adhesive Capsulitis (Frozen Shoulder): A Comprehensive Clinical Monograph

1. Comprehensive Introduction & Overview

Adhesive Capsulitis, colloquially known as "Frozen Shoulder," is a debilitating clinical condition characterized by the progressive restriction of both active and passive glenohumeral range of motion (ROM). It is primarily attributed to a chronic inflammatory process leading to fibrosis and contracture of the glenohumeral joint capsule.

The condition affects approximately 2% to 5% of the general population, with a significantly higher prevalence in individuals aged 40 to 60. While often self-limiting, the natural history of the disease can span anywhere from 12 to 36 months, leading to significant morbidity, sleep disturbance, and loss of functional independence. As clinical specialists, it is imperative to distinguish between primary (idiopathic) adhesive capsulitis and secondary adhesive capsulitis, which arises from systemic comorbidities such as diabetes mellitus or post-traumatic/post-surgical sequelae.

2. Etiology and Pathophysiology: The Mechanics of Fibrosis

The pathophysiology of adhesive capsulitis is rooted in the transformation of the synovial lining and the capsuloligamentous complex.

The Cellular Mechanism

The process begins with an inflammatory phase involving synovial hyperplasia and neoangiogenesis. As the condition progresses, a transition to a proliferative fibroblastic phase occurs.
* Fibroblast Proliferation: Increased expression of transforming growth factor-beta (TGF-β) stimulates fibroblasts to differentiate into myofibroblasts.
* Collagen Deposition: Type I and Type III collagen are deposited in a disorganized, cross-linked fashion, particularly within the rotator interval—the space between the supraspinatus and subscapularis tendons.
* Capsular Contracture: The coracohumeral ligament becomes thickened and inelastic, effectively "tethering" the humeral head and restricting rotation, particularly external rotation.

3. Clinical Staging and Presentation

The clinical diagnosis is largely based on the patient’s history and physical examination findings, categorized into four distinct stages (the Reeves Staging System):

1. Stage 1 (Pre-adhesive/Freezing): Lasts 0–3 months. Characterized by sharp pain at end-range and aching at rest. Physical exam shows minimal loss of motion.
2. Stage 2 (Freezing): Lasts 3–9 months. Characterized by intense, constant pain. Significant loss of motion in all planes, especially external rotation.
3. Stage 3 (Frozen): Lasts 9–15 months. Pain begins to subside, but stiffness is maximal. The joint feels "rigid" upon passive manipulation.
4. Stage 4 (Thawing): Lasts 15–24 months. Pain is minimal; however, structural stiffness persists, slowly resolving through remodeling of the capsule.

Standard Presentation

Patients typically present with:
* Insidious onset of shoulder pain.
* Difficulty with Activities of Daily Living (ADLs) such as reaching behind the back (internal rotation), brushing hair, or fastening a bra.
* Pain that is frequently worse at night, often preventing sleep on the affected side.

4. Diagnostic Assessment and Differential Diagnosis

Key Diagnostic Criteria

The hallmark of adhesive capsulitis is a capsular pattern of restriction:
* Greatest loss: External Rotation (ER).
* Moderate loss: Abduction.
* Least loss: Internal Rotation (IR).
* Crucial Diagnostic Sign: Significant limitation in both active and passive range of motion. If passive ROM is preserved, the pathology is likely muscular or neurological rather than capsular.

Differential Diagnosis

Clinical specialists must rule out conditions that mimic frozen shoulder:
* Glenohumeral Osteoarthritis: Usually presents with crepitus and radiographic evidence of joint space narrowing.
* Rotator Cuff Tear: Usually presents with normal passive ROM but limited active ROM.
* Cervical Radiculopathy: Pain radiates into the shoulder but is reproduced by cervical spine maneuvers (e.g., Spurling’s test).
* Septic Arthritis/Neoplasm: Red flags include systemic symptoms (fever, chills, night sweats) or localized bony tenderness.

Imaging Modalities

• Radiographs (X-ray): Primarily used to rule out glenohumeral arthritis or calcific tendinitis.
• MRI/MRA: Can demonstrate thickening of the coracohumeral ligament (>4mm) and obliteration of the rotator interval fat triangle.
• Ultrasound: Often shows synovial hypertrophy and increased vascularity (power Doppler).

5. Clinical Indications and Management Strategy

Treatment is dictated by the stage of the disease.

• Conservative Management (Stages 1 & 2):

  • Pharmacology: NSAIDs and short-term oral corticosteroids for pain modulation.
  • Intra-articular Injections: Corticosteroid injections are highly effective in the early inflammatory stage to reduce synovial inflammation.
  • Physical Therapy: Focus on gentle, pain-free ROM exercises. Aggressive stretching is contraindicated in the "freezing" phase as it may exacerbate the inflammatory response.

• Interventional/Surgical Management (Stages 3 & 4):

  • Hydrodilatation: Ultrasound-guided injection of saline and local anesthetic/steroid to mechanically stretch the capsule.
  • Manipulation Under Anesthesia (MUA): Forceful passive movement to rupture the fibrotic adhesions.
  • Arthroscopic Capsular Release: Surgical resection of the thickened, fibrotic portions of the capsule, specifically the rotator interval and the inferior glenohumeral ligament.

6. Risks, Side Effects, and Contraindications

• Corticosteroid Injections: Risks include post-injection flare, subcutaneous atrophy, and potential for tendon weakening if administered too frequently.
• MUA/Surgery: Potential for humeral shaft fractures (in osteopenic patients), iatrogenic rotator cuff tears, or nerve injury (axillary nerve).
• Contraindications: Do not perform aggressive manipulation in patients with acute inflammatory systemic conditions (e.g., Rheumatoid Arthritis) without rheumatological clearance.

7. Long-Term Prognosis

While the prognosis for adhesive capsulitis is generally favorable, it is a diagnosis of patience.
* Complete Resolution: 70–90% of patients achieve near-full recovery within 2 years.
* Residual Deficits: A small subset of patients (10–15%) may experience chronic, mild, or moderate stiffness that does not fully resolve, though this rarely impacts functional quality of life significantly.
* Recurrence: Recurrence in the same shoulder is rare, but the contralateral shoulder is affected in approximately 10–20% of cases.

8. Massive FAQ Section

1. Is "Frozen Shoulder" the same as a Rotator Cuff Tear?
No. A rotator cuff tear involves damage to the tendons, usually resulting in weakness and limited active motion, while passive motion remains intact. Adhesive capsulitis restricts both active and passive motion.

2. Can physical therapy make it worse?
Yes. In the initial "freezing" phase, aggressive physical therapy can increase inflammation. Therapy should focus on gentle, pain-free mobility during this period.

3. Why is it so painful at night?
The inflammatory nature of the joint capsule leads to localized swelling. When lying down, the lack of muscle activation and changes in blood flow can increase intra-articular pressure, exacerbating pain.

4. How long does the recovery process take?
The full cycle lasts between 12 and 36 months, though the most severe pain usually subsides within the first 6–9 months.

5. Is diabetes a risk factor?
Yes. Patients with Type 1 or Type 2 Diabetes are at a significantly higher risk (up to 20% prevalence) for developing adhesive capsulitis.

6. What is the role of hydrodilatation?
It is a procedure where fluid is injected into the joint to expand the capsule, helping to break up internal adhesions. It is most effective when combined with a home exercise program.

7. Do I need surgery?
Surgery is usually reserved for patients who have failed 6 months of conservative treatment and continue to suffer from significant functional impairment.

8. Can I prevent frozen shoulder?
While primary adhesive capsulitis is often idiopathic, maintaining shoulder mobility after injury or surgery is the best preventative measure.

9. Are there any dietary changes that help?
While no specific diet cures the condition, an anti-inflammatory diet (rich in Omega-3s and antioxidants) may help manage systemic inflammation.

10. Will the shoulder ever be 100% "normal" again?
Most patients regain near-full function. However, some may perceive a slight difference in end-range mobility compared to their unaffected side, which is usually asymptomatic.

9. Summary for Clinical Practice

Adhesive capsulitis remains a diagnosis of clinical acumen. By identifying the stage of the pathology and tailoring interventions to the specific inflammatory or fibrotic phase, the clinician can effectively manage patient expectations and optimize outcomes. The primary objective is to maintain as much function as possible during the painful phase while facilitating the natural resolution process through targeted, evidence-based interventions.